PATENT CLAIM ANALYSIS

Application Number: 16013019
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["548", "362100"]

Abstract:
The present invention relates to substituted indazole compounds which modulate the activity of protein kinases and are therefore useful in treating diseases caused by degulated protein kinase activity, like cancer. The present invention also provides methods for preparing these compounds, pharmaceutical compositions comprising these compounds, and methods of treating diseases utilizing such these compounds or the pharmaceutical compositions containing them.

Claim (Index 33):
A product comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, as defined in  claim 27 , and one or more chemotherapeutic agents, as a combined preparation for simultaneous, separate or sequential use in anticancer therapy.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 94.0
- Lexical Diversity: 1.47727
- Patent Class: 548.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15203087', '15203092', '12520387', '13140208', '12668745']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7671291628742456
- 35 USC 102 Novelty (BERT): 0.5811456787250022
- Combined Prediction Score: 0.7485308144593213
- Mean Citation Score: 462.263366
- Max Citation Score: 502.09686
- Similarity Product: 400.4956946389818

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test